New treatment option combines proven efficacy and established safety profile of buprenorphine with a novel delivery system that adds convenience and flexibility Endo Pharmaceuticals Inc., a subsidiary ...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Purdue Pharma (Canada) announced today that BELBUCA® (buprenorphine) buccal film is now commercially available in Canada. The first ...
A new medication for chronic pain has been approved in the United States, a buprenorphine buccal film product, trade name: Belbuca. It is indicated for the treatment of chronic pain severe enough to ...
Oct 26 (Reuters) - BioDelivery Sciences International Inc said the U.S. Food and Drug Administration had approved its opioid treatment for chronic pain, sending the drugmaker's shares up 23 percent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results